Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ia, Mandjes"'
Autor:
Judith Kroep, Sc, Linn, Boven E, Hj, Bloemendal, Baas J, Ia, Mandjes, van den Bosch J, Wm, Smit, de Graaf H, Cp, Schröder, Gj, Vermeulen, Wc, Hop, Jw, Nortier
Publikováno v:
Europe PubMed Central
Lapatinib, a tyrosine kinase inhibitor of human epidermal growth factor receptor 2 (HER2), has shown activity in combination with capecitabine in patients with HER2-positive advanced breast cancer progressive on standard treatment regimens. We presen
Autor:
van der Voort A; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Louis FM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Ramshorst MS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Kessels R; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands., Mandjes IA; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands., Kemper I; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Agterof MJ; Department of Medical Oncology, St Antonius Hospital, Nieuwegein, Netherlands., van der Steeg WA; Department of Medical Oncology, Isala, Zwolle, Netherlands., Heijns JB; Department of Medical Oncology, Amphia, Breda, Netherlands., van Bekkum ML; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, Netherlands., Siemerink EJ; Department of Medical Oncology, Ziekenhuisgroep Twente, Hengelo, Netherlands., Kuijer PM; Department of Medical Oncology, Spaarne Gasthuis Hoofdorp, Netherlands., Scholten A; Department of Radiation, Netherlands Cancer Institute, Amsterdam, Netherlands., Wesseling J; Division of Molecular Pathology and Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre, Leiden, Netherlands., Vrancken Peeters MTFD; Department of Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Surgery, Amsterdam University Medical Centre, Amsterdam, Netherlands., Mann RM; Department of Radiology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Imaging, Radboud University Medical Center, Amsterdam, Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Amsterdam University Medical Centre, Amsterdam, Netherlands. Electronic address: g.sonke@nki.nl.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 May; Vol. 25 (5), pp. 603-613. Date of Electronic Publication: 2024 Apr 05.
Autor:
van der Voort A; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., van Ramshorst MS; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands., van Werkhoven ED; Department of Biometrics, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IA; Department of Biometrics, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Kemper I; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Vulink AJ; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, the Netherlands., Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, the Netherlands., Honkoop AH; Department of Medical Oncology, Isala, Zwolle, the Netherlands., Tick LW; Department of Medical Oncology, Maxima Medical Center, Eindhoven, the Netherlands., van de Wouw AJ; Department of Medical Oncology, VieCuri Medical Center, Venlo, the Netherlands., Mandigers CM; Department of Medical Oncology, Canisius Wilhelmina hospital, Nijmegen, the Netherlands., van Warmerdam LJ; Department of Medical Oncology, Catharina Cancer Centre, Eindhoven, the Netherlands., Wesseling J; Department of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Vrancken Peeters MT; Department of Surgery, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Linn SC; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Publikováno v:
JAMA oncology [JAMA Oncol] 2021 Jul 01; Vol. 7 (7), pp. 978-984.
Autor:
van Ramshorst MS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van der Voort A; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Werkhoven ED; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands., Mandjes IA; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands., Kemper I; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Dezentjé VO; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, Netherlands., Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, Netherlands., Honkoop AH; Department of Medical Oncology, Isala, Zwolle, Netherlands., Tick LW; Department of Medical Oncology, Maxima Medical Center, Eindhoven, Netherlands., van de Wouw AJ; Department of Medical Oncology, VieCuri Medical Center, Venlo, Netherlands., Mandigers CM; Department of Medical Oncology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands., van Warmerdam LJ; Department of Medical Oncology, Catharina Cancer Centre, Eindhoven, Netherlands., Wesseling J; Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., Vrancken Peeters MT; Department of Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands., Linn SC; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre, Utrecht, Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: g.sonke@nki.nl.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2018 Dec; Vol. 19 (12), pp. 1630-1640. Date of Electronic Publication: 2018 Nov 06.
Autor:
van Ramshorst MS; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van Werkhoven E; Department of Biometrics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Honkoop AH; Department of Medical Oncology, Isala, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands., Dezentjé VO; Department of Medical Oncology, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD Delft, The Netherlands., Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Zilvermeeuw 1, 7609 PP Almelo, The Netherlands., Mandjes IA; Department of Biometrics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Kemper I; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Smorenburg CH; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Stouthard JM; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Linn SC; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: g.sonke@nki.nl.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2016 Oct; Vol. 29, pp. 153-9. Date of Electronic Publication: 2016 Aug 05.
Autor:
Jebbink M; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Werkhoven E, Mandjes IA, Wesseling J, Lips EH, Vrancken Peeters MJ, Loo CE, Sonke GS, Linn SC, Falo Zamora C, Rodenhuis S
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2015 Aug; Vol. 153 (1), pp. 145-52. Date of Electronic Publication: 2015 Jul 26.
Autor:
Rigter LS; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066, The Netherlands., Loo CE, Linn SC, Sonke GS, van Werkhoven E, Lips EH, Warnars HA, Doll PK, Bruining A, Mandjes IA, Vrancken Peeters MJ, Wesseling J, Gilhuijs KG, Rodenhuis S
Publikováno v:
British journal of cancer [Br J Cancer] 2013 Dec 10; Vol. 109 (12), pp. 2965-72. Date of Electronic Publication: 2013 Oct 22.
Autor:
Lips EH; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mulder L, de Ronde JJ, Mandjes IA, Koolen BB, Wessels LF, Rodenhuis S, Wesseling J
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2013 Jul; Vol. 140 (1), pp. 63-71. Date of Electronic Publication: 2013 Jul 05.
Autor:
Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. g.sonke@nki.nl, Mandjes IA, Holtkamp MJ, Schot M, van Werkhoven E, Wesseling J, Vrancken Peeters MJ, Rodenhuis S, Linn SC
Publikováno v:
The breast journal [Breast J] 2013 Jul-Aug; Vol. 19 (4), pp. 419-26. Date of Electronic Publication: 2013 May 20.
Autor:
Lips EH; Departments of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mulder L, de Ronde JJ, Mandjes IA, Vincent A, Vrancken Peeters MT, Nederlof PM, Wesseling J, Rodenhuis S
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2012 Feb; Vol. 131 (3), pp. 827-36. Date of Electronic Publication: 2011 Apr 07.